13 ADHD Clinical Trials in Bethesda, MD (2026)

Q: How do I join a clinical trial in Bethesda?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Bethesda research site will contact you.

Recruiting ADHD Studies in Bethesda

NCT06995898Recruiting

The Vanguard Study: Testing a New Way to Screen for Cancer

The Vanguard Study is a feasibility study to explore several aspects of evaluating multi-cancer detection (MCD) tests in a future definitive randomized controlled trial. An MCD test measures markers i...

Bethesda, MDNA24,000 participantsNational Cancer Institute (NCI)

View Study Details

NCT02379429Recruiting

Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue

Background: Urothelial cancer is cancer of the bladder, ureter, and urethra. Researchers want to better understand what changes in a person s cells and genes cause this cancer to form. This may help ...

Bethesda, MD500 participantsNational Cancer Institute (NCI)

View Study Details

NCT05608434Recruiting

Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial

Background: Children with attention deficit hyperactivity disorder (ADHD) often have cognitive problems. It may be hard for them to control their behaviors, concentrate for long periods, or make deci...

Bethesda, MDPHASE1219 participantsNational Institute of Mental Health (NIMH)

View Study Details

NCT04020510Recruiting

Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder

OnabotulinumtoxinA is an effective treatment for both idiopathic and neurogenic overactive bladder and was FDA approved for this indication in 2013. The standard technique for injecting onabotulinumto...

Bethesda, MDPHASE4184 participantsWalter Reed National Military Medical Center

View Study Details

NCT06729151Recruiting

Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain Syndrome

Interstitial cystitis/bladder pain syndrome (IC/BPS) is estimated to affect 3.3 to 7.9 million women aged 18 years and older in the United States. The American Urological Association (AUA) defines IC/...

Bethesda, MD159 participantsWalter Reed National Military Medical Center

View Study Details

NCT05221021Recruiting

Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome

A single site, double-blinded, randomized controlled trial for postmenopausal women with urinary frequency, urgency, nocturia with or without urgency urinary incontinence symptoms. Patient's will be r...

Bethesda, MDPHASE4152 participantsWalter Reed National Military Medical Center

View Study Details

NCT06387329Recruiting

Bladder Botox UTI Antibiotic Prophylaxis

Overactive bladder (OAB) is a common condition with a prevalence of 17% in the general population that significantly affects quality of life. Intradetrusor onabotulinumtoxinA injections are an advance...

Bethesda, MDPHASE4100 participantsWalter Reed National Military Medical Center

View Study Details

NCT05521698Recruiting

A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer

This phase I trial evaluates the effects of bicalutamide, compared to no study drug (NSD), on epidermal growth factor receptor (EGFR) protein expression in patients with non-muscle invasive bladder ca...

Bethesda, MDPHASE180 participantsUniversity of Wisconsin, Madison

View Study Details

NCT06041503Recruiting

Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)

Background: Many cancers of the testicles and urinary tract are rare diseases; these are diseases that affect less than 200,000 people in the United States. It can be hard to study treatments for the...

Bethesda, MDPHASE268 participantsNational Cancer Institute (NCI)

View Study Details

NCT06161532Recruiting

Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...

Background: Rare tumors of the genitourinary (GU) tract can appear in the kidney, bladder, ureters, and penis. Rare tumors are difficult to study because there are not enough people to conduct large ...

Bethesda, MDPHASE260 participantsNational Cancer Institute (NCI)

View Study Details

NCT06228066Recruiting

Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)

Background: Small cell carcinoma of the bladder (SCCB) and other high-grade neuroendocrine tumors (HGNET) of the urinary tract are rare but aggressive cancers. Average survival for people diagnosed w...

Bethesda, MDPHASE245 participantsNational Cancer Institute (NCI)

View Study Details

NCT04235764Recruiting

En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device

Background: Bladder cancer is the sixth most common cancer in the United States. The way that doctors remove tumors in bladder surgeries may leave some cancer . Also, many people have their tumors re...

Bethesda, MD25 participantsNational Cancer Institute (NCI)

View Study Details

NCT06204874Recruiting

New Approaches to Nerve Stimulation Therapy for Bladder Pain Syndrome

Many women suffer from bladder pain syndrome (BPS). There are many treatments, but there is no one universally effective option. The goal of this clinical trial is to explore the use of electrical ene...

Bethesda, MDNA5 participantsWalter Reed National Military Medical Center

View Study Details

About ADHD Clinical Trials in Bethesda

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity that interferes with functioning. It affects both children and adults. Treatment includes behavioral therapy, stimulant and non-stimulant medications, and educational support.

There are currently 13 adhd clinical trials recruiting participants in Bethesda, MD. These studies are seeking a combined 25,597 participants. Research is being sponsored by National Cancer Institute (NCI), National Institute of Mental Health (NIMH), Walter Reed National Military Medical Center and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

ADHD Clinical Trials in Bethesda — FAQ

Are there adhd clinical trials in Bethesda?

Yes, there are 13 adhd clinical trials currently recruiting in Bethesda, MD. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Bethesda?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Bethesda research site will contact you about next steps.

Are clinical trials in Bethesda free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Bethesda studies also compensate for your time and travel.

What adhd treatments are being tested?

The 13 active trials in Bethesda are testing new therapies including novel drugs, biologics, and treatment approaches for adhd.

Data updated July 17, 2026 from ClinicalTrials.gov